Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:October 10, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:October 10, 2019Unknown status
Condition(s):Urinary Tract Infection; FeverLast Updated:November 6, 2014Completed
Condition(s):InfectionLast Updated:May 24, 2023Completed
Condition(s):Urinary Tract Infection; Fluoroquinolone; BacteremiaLast Updated:June 12, 2018Completed
Condition(s):Colonization; Multi Drug Resistant Bacteria; Hospitalized PatientsLast Updated:June 23, 2015Completed
Condition(s):Corneal UlcersLast Updated:August 13, 2015Terminated
Condition(s):Multiple MyelomaLast Updated:February 20, 2024Recruiting
Condition(s):Fluoroquinolone Resistant Enteric BacteriaLast Updated:May 17, 2017Completed
Condition(s):Tuberculosis; Human Immunodeficiency VirusLast Updated:August 25, 2023Recruiting
Condition(s):Infective EndocarditisLast Updated:May 19, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.